Use in Cancer Treatment

Marketing Authorization Holder: Protherics Medicines Development, Ltd

BTG is a registered trademark of BTG International Ltd.

SERB^® and the SERB logo are registered trademarks of SERB S.à.r.l.

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard. or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to vigilance@btgsp.com

^Ⓒ 2025 BTG International Inc. All rights reserved.
UK-VRX-2300076 Date of Last Revision: February 2024

Order Voraxaze

01865 904141

24-hour Medical Information

0800 358 0897